| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/03/2010 | CN101663290A Compounds comprising a cyclobutoxy group |
| 03/03/2010 | CN101663289A Piperazinyl-propyl-pyrazole derivatives as dopamine d4 receptor antagonists, and pharmaceutical compositions containing the same |
| 03/03/2010 | CN101659658A Quinoline substituted by cyan |
| 03/03/2010 | CN101659657A Quinoline substituted by cyan and preparation method and applications thereof |
| 03/03/2010 | CN101659656A Pyridyl oxime ether derivative, preparation and application thereof |
| 03/03/2010 | CN101659655A Pyrazole amide derivative and application thereof |
| 03/03/2010 | CN101659654A 2-Methylpiperazine fluoroquinolone compound and preparation method and application thereof |
| 03/03/2010 | CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/02/2010 | US7671209 Regiospecific synthesis of nicotine derivatives |
| 03/02/2010 | US7671208 Acetone solvate of phthaloyl amlodipine |
| 03/02/2010 | US7671206 Synthesis and uses of pyroglutamic acid derivatives |
| 03/02/2010 | US7671205 6-aminoisoquinoline compounds |
| 03/02/2010 | US7671201 Phenyl substituted cyclic derivatives |
| 03/02/2010 | US7671077 Kits for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis (ALS) |
| 03/02/2010 | US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 03/02/2010 | US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors |
| 03/02/2010 | US7671072 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke |
| 03/02/2010 | US7671056 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction |
| 03/02/2010 | US7671055 Insecticidal 3-(dihaloalkenyl) phenyl derivatives |
| 03/02/2010 | US7671053 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide for treatment of asthma and COPD; purinergic receptors (P2X7) |
| 03/02/2010 | US7671049 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 03/02/2010 | US7670205 Crotch-possessing corrective garment |
| 02/25/2010 | WO2010022196A2 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 02/25/2010 | WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010021878A1 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
| 02/25/2010 | WO2010020981A1 A3 adenosine receptor allosteric modulators |
| 02/25/2010 | WO2010020810A1 2-(imidaz0lylamin0)-pyridine derivatives and their use as jak kinase inhibitors |
| 02/25/2010 | WO2010020762A1 1,5-diaryl-pyrazoles and their use as cannabinoid receptor neutral antagonists |
| 02/25/2010 | WO2010020672A1 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/25/2010 | WO2010020628A1 Novel production method for l-piperidine-4-yl-1,3-dihydro-imidazo [4,5-b] pyridine-2-one and mono- and dihydrochlorides thereof |
| 02/25/2010 | WO2010020432A2 Compounds for treatment of duchenne muscular dystrophy |
| 02/25/2010 | WO2010020363A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009155001A3 Wnt protein signalling inhibitors |
| 02/25/2010 | WO2009152356A3 Compounds and compositions useful for the treatment of malaria |
| 02/25/2010 | WO2009087238A9 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/25/2010 | WO2002068414A8 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/25/2010 | US20100048907 Indazolamides with analgesic activity |
| 02/25/2010 | US20100048895 Process for Preparing Heterocyclic Derivatives |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048890 Conjugated small molecules |
| 02/25/2010 | US20100048640 Hydrazide compound and harmful arthropod-controlling agent containing the same |
| 02/25/2010 | US20100048638 Heparan sulfate inhibitors |
| 02/25/2010 | US20100048635 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 02/25/2010 | US20100048633 Piperidine-4-acrylamides |
| 02/25/2010 | US20100048626 Aryl Substituted Pyridines and the Use Thereof |
| 02/25/2010 | US20100048617 Compounds |
| 02/25/2010 | US20100048613 Polymorphic form of granisetron hydrochloride and methods of making the same |
| 02/25/2010 | US20100048610 Carbinol derivatives having cyclic linker |
| 02/25/2010 | US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 02/25/2010 | US20100048599 Compounds As Kinase Inhibitors |
| 02/25/2010 | US20100048597 Organic Compounds and Their Uses |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048585 Quinoline derivatives as antibacterial agents |
| 02/25/2010 | US20100048584 Pyridyl derivatives and their use as therapeutic agents |
| 02/25/2010 | US20100048583 Novel Heterocyclic NF-kB Inhibitors |
| 02/25/2010 | US20100048582 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
| 02/25/2010 | US20100048581 Thiazolyl compounds useful as kinase inhibitors |
| 02/25/2010 | US20100048580 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/25/2010 | US20100048579 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonists |
| 02/25/2010 | US20100048578 Hydrazide compound and harmful arthropod-controlling agent containing the same |
| 02/25/2010 | US20100048576 PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS |
| 02/25/2010 | US20100048574 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 02/25/2010 | US20100048571 Organic Compounds |
| 02/25/2010 | US20100048569 Diazole derivatives |
| 02/25/2010 | US20100048568 Pyrimidine hydrazide compounds as pgds inhibitors |
| 02/25/2010 | US20100048566 Antibacterial quinoline derivatives |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048564 Fused bicyclic heteroaryl derivative |
| 02/25/2010 | US20100048561 Quinazolines for pdk1 inhibition |
| 02/25/2010 | US20100048560 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 02/25/2010 | US20100048543 Pyrimidine compounds having ties (tek) inhibitory activity |
| 02/25/2010 | US20100048541 Substituted lactams as inhibitors of abeta protein production |
| 02/25/2010 | US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | US20100048447 Bis(hydroxyquinoline) metal complexes as bleach catalysts |
| 02/25/2010 | US20100047660 Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups |
| 02/25/2010 | US20100044695 Compound for organic electroluminescent device and organic electroluminescent device |
| 02/25/2010 | DE102008039083A1 Substituierte 5-Aminopyrazole und ihre Verwendung Substituted 5-aminopyrazoles and their use |
| 02/25/2010 | DE102008039082A1 Azabicyclisch-substituierte 5-Aminopyrazole und ihre Verwendung Azabicyclisch-substituted 5-aminopyrazoles and their use |
| 02/25/2010 | CA2734877A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 02/25/2010 | CA2734787A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/24/2010 | EP2157090A1 Pyrazinamide compound |
| 02/24/2010 | EP2157087A1 3-(4-{[4-(4-{[3-(3,3-dimethyl-1-piperidinyl)propyl]oxy}phenyl)-1-piperidinyl]carbonyl}-1-naphthalenyl)propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 02/24/2010 | EP2157084A1 5-phenyl-3-pyridazinone derivative |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2157077A1 Method for producing triarylamine compound |
| 02/24/2010 | EP2155723A2 New solid forms of fxa inhibitors |
| 02/24/2010 | EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 02/24/2010 | EP2155721A1 Organic compounds |
| 02/24/2010 | EP2155720A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 02/24/2010 | EP2155719A1 Azacyclylbenzamide derivatives as histamine-3 antagonists |